Development of modern gene therapy approaches necessitates exact gene expression control to be suited for the highly complex in vivo environment.
The SIRION technology platform offers versatile options to identify and optimize the best possible approach for YOUR R&D.
Tissue specific AAV design.
Lentivirus retargeting to pinpoint cell specific expression.
CONTACT US – Discuss how we can add value to your therapeutic R&D.